134 related articles for article (PubMed ID: 11268891)
1. [Superficial pyoderma requiring oral antibiotic therapy: fusidic acid versus pristinamycin]].
Claudy A;
Presse Med; 2001 Mar; 30(8):364-8. PubMed ID: 11268891
[TBL] [Abstract][Full Text] [Related]
2. [Pristinamycin versus oxacillin in the treatment of superficial pyoderma. A multicenter randomized study in 293 outpatients].
Bernard P; Vaillant L; Martin C; Beylot C; Quentin R; Touron D
Ann Dermatol Venereol; 1997; 124(5):384-9. PubMed ID: 9739895
[TBL] [Abstract][Full Text] [Related]
3. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
[TBL] [Abstract][Full Text] [Related]
4. Fusidic acid suspension twice daily: a new treatment schedule for skin and soft tissue infection in children, with improved tolerability.
Török E; Somogyi T; Rutkai K; Iglesias L; Bielsa I
J Dermatolog Treat; 2004 Jun; 15(3):158-63. PubMed ID: 15204148
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].
Macotela-Ruiz E; Durán Bermúdez H; Kuri Con FJ; Arevalo López A; Villalobos Ibarra JL
Med Cutan Ibero Lat Am; 1988; 16(2):171-3. PubMed ID: 3050336
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
Craft JC; Moriarty SR; Clark K; Scott D; Degenhardt TP; Still JG; Corey GR; Das A; Fernandes P
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S520-6. PubMed ID: 21546629
[TBL] [Abstract][Full Text] [Related]
7. Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open-label, non-inferiority study.
Chosidow O; Bernard P; Berbis P; Humbert P; Crickx B; Jarlier V;
Dermatology; 2005; 210(4):370-4. PubMed ID: 15942235
[TBL] [Abstract][Full Text] [Related]
8. [Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients].
Bernard P; Risse L; Bonnetblanc JM
Ann Dermatol Venereol; 1996; 123(1):16-20. PubMed ID: 8734110
[TBL] [Abstract][Full Text] [Related]
9. Fusidic acid in skin and soft tissue infections.
Spelman D
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S59-66. PubMed ID: 10528787
[TBL] [Abstract][Full Text] [Related]
10. [Managing children skin and soft tissue infections].
Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
[TBL] [Abstract][Full Text] [Related]
11. [Controlled study of pristinamycin versus oxacillin in staphylococcal infections ].
Bastin R; Rapin M; Kernbaum S
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):473-5. PubMed ID: 6812003
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
Clark SM; Loeffler A; Bond R
J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003
[TBL] [Abstract][Full Text] [Related]
13. Fusidic acid in skin infections and infected atopic eczema.
Bonamonte D; Belloni Fortina A; Neri L; Patrizi A
G Ital Dermatol Venereol; 2014 Aug; 149(4):453-9. PubMed ID: 25068235
[TBL] [Abstract][Full Text] [Related]
14. [Staphylomycin in dermatology. Experimental and clinical experiences].
Meyer-Rohn J
Munch Med Wochenschr; 1968 Mar; 110(12):730-3. PubMed ID: 4877261
[No Abstract] [Full Text] [Related]
15. Fusidic acid betamethasone lipid cream.
Girolomoni G; Mattina R; Manfredini S; Vertuani S; Fabrizi G
Int J Clin Pract; 2016 May; 70 Suppl 184():4-13. PubMed ID: 27121235
[TBL] [Abstract][Full Text] [Related]
16. A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma.
Avci O; Tanyildizi T; Kusku E
J Dermatolog Treat; 2013 Feb; 24(1):70-4. PubMed ID: 21923567
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
[TBL] [Abstract][Full Text] [Related]
18. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
[TBL] [Abstract][Full Text] [Related]
19. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B
Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879
[TBL] [Abstract][Full Text] [Related]
20. Fusidic acid in dermatology: an updated review.
Schöfer H; Simonsen L
Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
